N-Cyclohexanecarbonylpentadecylamine is a selective inhibitor of acidic palmitoyl ethanolamidase (PEAase, IC50 = 4.5 µM). It does not, however, inhibit FAAH, even at concentrations as high as 100 µM.
1. Khanolkar, A D., et al., 1999. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand. Life sciences. 65(6-7): 607-16. PMID: 10462061
2. Deutsch, D G., et al., 2001. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. The Journal of biological chemistry. 276(10): 6967-73. PMID: 11118429
3. Ueda, N., et al., 2001. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. The Journal of biological chemistry. 276(38): 35552-7. PMID: 11463796
4. Tsuboi, Kazuhito., et al., 2004. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. The Biochemical journal. 379(Pt 1): 99-106. PMID: 14686878
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.